Neumora Therapeutics (NMRA) Tax Provisions (2024 - 2026)
Neumora Therapeutics (NMRA) posted quarterly Tax Provisions of $30000.0 for Q1 2026, down 71.43% year-over-year from $105000.0 in Q1 2025, and up 160.0% quarter-over-quarter from -$50000.0 in Q4 2025.
Neumora Therapeutics (NMRA) Tax Provisions (2024 - 2026) Analysis & Trends
Neumora Therapeutics' Tax Provisions history runs 3 years deep, the most recent figure standing at $30000.0 for Q1 2026.
- In Q1 2026, Tax Provisions fell 71.43% year-over-year to $30000.0; the TTM figure through Mar 2026 stood at $5000.0 (down 98.23% YoY), while the FY2025 annual figure was $80000.0, down 55.06% from the prior year.
- Tax Provisions for Q1 2026 stood at $30000.0, up from -$50000.0 in the prior quarter.
- The five-year high for Tax Provisions was $125000.0 in Q2 2024, with the low at -$50000.0 in Q4 2025.
- The 3-year median for Tax Provisions is $41500.0 (2024), against an average of $48000.0.
- The sharpest annual moves came in 2025 and 2026: Tax Provisions sank 80.0% in 2025, then tumbled 71.43% in 2026.
- Neumora Therapeutics' Tax Provisions stood at $53000.0 in 2024, then sank by 194.34% to -$50000.0 in 2025, then jumped by 160.0% to $30000.0 in 2026.
- Business Quant data shows NMRA's Tax Provisions at $30000.0 in Q1 2026, -$50000.0 in Q4 2025, and $25000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Neumora Therapeutics | 296.45 Mn | 296.45 Mn | - | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | -50,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 105,000.00 |
| Sep 30, 2024 | 53,000.00 |
| Jun 30, 2024 | 125,000.00 |